Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
07.04. | KORU Medical Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
12.03. | KORU Medical Systems, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
12.03. | KORU Medical Systems, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
12.03. | KORU Medical Systems, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
14.02. | Piper Sandler cuts Koru Medical stock rating to neutral | 1 | Investing.com | ||
07.02. | KORU Medical Systems signs agreement for subcutaneous immunoglobulin infusion system | 2 | Seeking Alpha | ||
KORU MEDICAL SYSTEMS Aktie jetzt für 0€ handeln | |||||
30.01. | KORU Medical kooperiert für Phase-III-Studie bei seltener Nierenerkrankung | 1 | Investing.com Deutsch | ||
30.01. | KORU Medical partners for Phase III trial in rare kidney disorder | 1 | Investing.com | ||
17.01. | Analyst Expectations For KORU Medical Systems' Future | 3 | Benzinga.com | ||
13.01. | KORU Medical Systems reports record Q4 and FY24 revenue | 1 | Seeking Alpha | ||
13.01. | KORU Medical reports 23% Q4 revenue growth | 1 | Investing.com | ||
13.01. | KORU Medical verzeichnet 23% Umsatzwachstum im vierten Quartal | 1 | Investing.com Deutsch | ||
13.01. | KORU Medical Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
13.01. | KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter | 99 | Business Wire | MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization... ► Artikel lesen | |
13.11.24 | KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance | 99 | Business Wire | MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization... ► Artikel lesen | |
13.11.24 | KORU Medical Systems, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
13.11.24 | KORU Medical Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
07.08.24 | KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance | 121 | Business Wire | MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization... ► Artikel lesen | |
05.06.24 | Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion | 707 | Business Wire | The companies, KORU Medical, manufacturer of the proprietary, large-volume, Freedom Infusion System (the "Freedom System") and SCHOTT Pharma, manufacturer of SCHOTT TOPPAC prefillable polymer... ► Artikel lesen | |
01.05.24 | KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth | 142 | Business Wire | MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PROCEPT BIOROBOTICS | 52,56 | 0,00 % | PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops | ||
BRIGHTSPRING HEALTH SERVICES | 16,550 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 18,040 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance | Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,740 | +1,87 % | EQS-DD: Siemens Healthineers AG: Darleen Caron, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
22.04.2025 / 17:45... ► Artikel lesen | |
FRESENIUS | 40,230 | +0,95 % | BARCLAYS stuft Fresenius SE auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Fresenius von 44,00 auf 43,50 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. Die Bad Homburger dürften... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 6,490 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2024 Results | SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 43,080 | +1,48 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 42,50 auf 40,50 Euro gesenkt, aber die Einstufung auf "Equal Weight" belassen. Die schwere Grippewelle... ► Artikel lesen | |
GERRESHEIMER | 54,35 | +1,40 % | UBS stuft GERRESHEIMER AG auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Gerresheimer von 106 auf 97 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Der Jahresstart sei schwach gewesen, schrieb... ► Artikel lesen | |
UNITEDHEALTH | 374,75 | +0,51 % | UnitedHealth Group-Aktie leicht im Minus (377,1447 €) | Am US-amerikanischen Aktienmarkt liegt die UnitedHealth Group-Aktie zur Stunde im Minus. Zuletzt zahlten Investoren für das Wertpapier 434,12 US-Dollar. Heute hat sich im US-amerikanischen Wertpapierhandel... ► Artikel lesen | |
CARL ZEISS MEDITEC | 58,85 | +0,17 % | Hat Carl Zeiss Meditec die Digitalisierung der Augenheilkunde in der Hand? | Der Jenaer Medizintechnikkonzern Carl Zeiss Meditec AG (DE0005313704) feiert einen beachtlichen Meilenstein im US-Markt: Mehr als zwei Millionen Kataraktoperationen wurden inzwischen mit dem digitalen... ► Artikel lesen | |
NUTEX HEALTH | 140,51 | 0,00 % | Nutex Health Inc. (NUTX): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout | ||
GENEDX | 109,22 | 0,00 % | GeneDx To Buy Fabric Genomics | ||
RXSIGHT | 14,730 | 0,00 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
ECKERT & ZIEGLER | 57,70 | +2,85 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler unterzeichnet Herstellungsvereinbarung mit Pentixapharm für Yttrium-90-basiertes PentixaTher | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Vereinbarung/Auftragseingänge
Eckert & Ziegler unterzeichnet Herstellungsvereinbarung mit Pentixapharm für Yttrium-90-basiertes... ► Artikel lesen | |
DOCGO | 2,220 | 0,00 % | Pre-market Movers: Interactive Strength, DocGo, DLocal, Iovance Biotherapeutics, Acadia Healthcare | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.00 A.M. ET).In the Green Interactive Strength Inc. (TRNR) is up over 30% at... ► Artikel lesen |